---
title: "Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290077142.md"
description: "Genenta Science SpA (GNTA) has scheduled a shareholder meeting for June 29, 2026, to vote on key corporate actions. These include approving 2025 financials, appointing the Board, and authorizing treasury share transactions. Crucially, shareholders will vote on changing the company's name to Saentra Forge S.p.A., increasing capital or issuing convertible bonds, and executing a reverse stock split. The reverse split aims to address Nasdaq listing compliance challenges."
datetime: "2026-06-17T13:30:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290077142.md)
  - [en](https://longbridge.com/en/news/290077142.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290077142.md)
generator: "portal-rs"
---

# Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split

Genenta Science SpA Sponsored ADR ( (GNTA) ) just unveiled an update.

Genenta Science has called an Ordinary and Extraordinary Shareholders’ Meeting to be held by teleconference on June 29, 2026, with a possible second call on June 30, 2026. In the ordinary session, shareholders will vote on approving the 2025 financial statements, appointing a new Board of Directors and setting its compensation, and authorizing the purchase and disposal of treasury shares.

In the extraordinary session, investors will be asked to approve a proposed change of the corporate name to Saentra Forge S.p.A., a delegation to the Board to increase share capital or issue convertible bonds, and a reverse stock split of ordinary shares, with the Board empowered to set the ratio. The potential reverse split is explicitly tied to addressing Genenta’s challenges in achieving stable compliance with Nasdaq listing requirements, signaling efforts to safeguard its U.S. listing and strengthen its financing flexibility. 

The most recent analyst rating on (GNTA) stock is a Buy  
 with a $7.00 price target.  
 To see the full list of analyst forecasts on Genenta Science SpA Sponsored ADR stock,  
 see the GNTA Stock Forecast page. 

**More about Genenta Science SpA Sponsored ADR**

Genenta Science S.p.A., a Milan-based biotechnology company, develops gene and cell therapy approaches for difficult-to-treat cancers and related conditions. The company is listed on Nasdaq via sponsored ADRs and operates under Italian corporate law, relying on shareholder meetings to approve key governance, capital structure and strategic decisions in its sector.

**Average Trading Volume:** 1,420,153

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $42.18M

Find detailed analytics on GNTA stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [GNTA.US](https://longbridge.com/en/quote/GNTA.US.md)

## Related News & Research

- [Western Forest Products announces annual shareholder meeting](https://longbridge.com/en/news/296542329.md)
- [MiniMed Group announces annual shareholder meeting](https://longbridge.com/en/news/296649574.md)
- [Jeanie Buss was only sibling who voted against selling shares](https://longbridge.com/en/news/296152709.md)
- [Vamos announces extraordinary shareholder meeting](https://longbridge.com/en/news/296008883.md)
- [Oando shareholders vote on cross-border share listing mandate at Sept. 17 AGM](https://longbridge.com/en/news/296196047.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**